InvestorsHub Logo
Followers 467
Posts 26917
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 1

Monday, 11/12/2012 9:49:36 AM

Monday, November 12, 2012 9:49:36 AM

Post# of 7
1:38AM Simcere Pharma receives approval from the FDA of China to begin first-in-man trials with APX003 (SCR) 8.02 : Apexigen announces that its partner, Simcere Pharmaceutical Group of Nanjing, received approval from the State Food and Drug Administration of China to begin first-in-man trials with APX003, which is also known as BD0801, for the treatment of cancer. With this approval, APX003/BD0801 becomes the first humanized monoclonal antibody derived from Apexigen's proprietary antibody technology platform to enter human trials.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SCR News